Glucagon-like peptide-1 (GLP-1) is an incretin hormone encoded together with glucagon by the proglucagon gene. It has been widely accepted that GLP-1 and glucagon are derived from distinct post-translational processing of proglucagon in a tissue specific manner. GLP-1 is produced in intestinal L-cells where proglucagon is processed by prohormone convertase 1/3 (PC1/3), while glucagon is produced in pancreatic α-cells via PC2-mediated cleavage. Nonetheless, emerging evidence has now demonstrated GLP-1 is also produced in pancreatic islets, although its concentration is much lower than glucagon. Further studies have shown GLP-1 production and secretion can be up-regulated by various factors, in particular, hyperglycemia and β-cell damage. The importance of locally produced GLP-1 in pancreas for β-cell function has started to be recognized. Similar to circulating GLP-1, α-cell produced GLP-1 can promote insulin secretion, protect β-cells and enhance β-cell proliferation, thus is vital for β-cell function. This review focuses on these recent discoveries regarding GLP-1 production in pancreatic islets and its action within pancreatic tissue.Keywords: GLP-1; Alpha cells; Islets; Diabetes; PC1/3
GLP-1: An OverviewGlucagon-like peptide-1 (GLP-1) is one of the peptide hormones encoded by the proglucagon gene, which gives rise to a number of individual peptides through posttranslational processing [1][2][3][4][5]. Based on its origin within the intestine and its vital role in stimulating insulin secretion, GLP-1 is considered a member of the incretin family. GLP-1 is intimately involved in the regulation of circulating blood glucose, acting to increase insulin secretion and sensitivity in a glucosedependent manner. It is well established that GLP-1 has many effects on multiple organ systems related to nutrient ingestion and blood glucose homeostasis [6,7]. In the gastrointestinal system, GLP-1 inhibits gastrointestinal motility, reduces gastric acid secretion, and slows gastric emptying [8][9][10][11]. GLP-1 has been shown to suppress appetite in both normal and obese individuals, thereby reducing food intake [12][13][14][15]. In the pancreas, GLP-1 stimulates insulin secretion from β-cells in a blood-glucose dependent manner, while also inhibiting glucagon secretion in α-cells, thus playing an essential role in blood glucose regulation [6,7].GLP-1 and glucagon share ~50% homology, deriving from the same precursor-proglucagon. The diversification takes place at the posttranslational stage in a tissue-specific manner (Figure 1). In pancreatic α-cells, proglucagon is mainly cleaved by prohormone Convertase 2 (PC2), giving rise to glucagon, Intervening Peptide-1 (IP-1), GlicentinRelated Polypeptide (GRPP), and the Major Proglucagon Fragment (MPGF) [16][17][18]. In contrast, in enteroendocrine L-cells, proglucagon is processed by prohormone convertase 1/3 (PC1/3), resulting in the production of GLP-1, GLP-2, glicentin, and several other small peptides [19,20].Nonetheless, emerging evidence has now demonstrated that GL...